跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Fexuclue - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Fexuclue
Approved
STANDARD
Fexuclue
Daewoong Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
570004d13a5f3f1f
Company
Daewoong Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
570004d13a5f3f1f
Drug Approval Philippines Name
Fexuclue
Product Name
Fexuclue
Registration Number
DR-XY48448
Brand Name
Fexuclue
Generic Name
Fexuprazan Hydrochloride
Dosage Form
Film-Coated Tablet
Dosage Strength
40mg
Manufacturer
Daewoong Pharmaceutical Co., Ltd.
Importer
Daewoong Pharma Philippines, Incorporated
Distributor
PNSV Asia Corporation
Company Detail Path
/organization/daewoong-pharmaceutical-co-ltd
Issuance Date
03 November 2022
Expiry Date
03 November 2027
Pharmacologic Category
Potassium-competitive acid blocker (P-CAB)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
570004d13a5f3f1f
Type
Standard
Back to Philippines FDA Approvals